Publications by authors named "Kevin Judice"

Claim this Profile
B
Bifunctional Small Molecules Enhance Neutrophil Activities Against and .
Caroline N Jones, Felix Ellett, Anne L Robertson, Kevin M Forrest, Kevin Judice

Front Immunol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Neutrophils Are Primed by Chemoattractant Gradients for Blocking the Growth of Aspergillus fumigatus.
Caroline N Jones, Laurie Dimisko, Kevin Forrest, Kevin Judice, Mark C Poznansky

J Infect Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multivalent approach to drug discovery for novel antibiotics.
Daniel D Long, James B Aggen, Burton G Christensen, J Kevin Judice, Sharath S Hegde

J Antibiot (Tokyo)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
Daniel D Long, James B Aggen, Jason Chinn, Seok-Ki Choi, Burton G Christensen, J Kevin Judice

J Antibiot (Tokyo)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telavancin (Theravance).
John L Pace, J Kevin Judice

Curr Opin Investig Drugs· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria.
Sharath S Hegde, Noe Reyes, Tania Wiens, Nicole Vanasse, Robert Skinner, J Kevin Judice

Antimicrob Agents Chemother· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424).
Michael R Leadbetter, Stacy M Adams, Bettina Bazzini, Paul R Fatheree, Dane E Karr, J Kevin Judice

J Antibiot (Tokyo)· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin disulfide derivatives as antibacterial agents.
YongQi Mu, Matthew Nodwell, John L Pace, Jeng Pyng Shaw, J Kevin Judice

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semi-synthetic glycopeptide antibacterials.
J Kevin Judice, John L Pace

Bioorg Med Chem Lett· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of TD-6424 against Staphylococcus aureus.
John L Pace, Kevin Krause, Deborah Johnston, Dmitri Debabov, Terry Wu, J Kevin Judice

Antimicrob Agents Chemother· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
John H Griffin, Martin S Linsell, Matthew B Nodwell, QiQi Chen, John L Pace, J Kevin Judice

J Am Chem Soc· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis